Skip to main content
Top
Published in: Virchows Archiv 3/2016

01-03-2016 | Original Article

Spatio-temporal genetic heterogeneity of CTNNB1 mutations in sporadic desmoid type fibromatosis lesions

Authors: Jérôme Doyen, Valérie Duranton-Tanneur, Isabelle Hostein, Marie Karanian-Philippe, Christine Chevreau, Florence Breibach, Michael Coutts, Bérengère Dadone, Marie-Christine Saint-Paul, Jean Gugenheim, Florence Duffaud, Florence Pedeutour

Published in: Virchows Archiv | Issue 3/2016

Login to get access

Abstract

Desmoid type fibromatosis (DT) is a rare lesion of unclear pathogenesis that most often presents a mutation of the (β-catenin) gene. The natural history and clinical evolution are highly variable between patients and to date there is no consensus on optimal therapy. We report two cases of a patient with multiple DT lesions. Molecular investigations performed in both patients on multiple tumors at different anatomical sites revealed non-identical CTNNB1 mutations. The first patient was a 39-year-old man with a history of recurrent DT. In two of the DT lesions, three different mutations were found in codons 41 and 45, respectively. The lesions showed marked inflammatory features, characterized by IgG4 positive lymphoplasmacytic infiltrates and a foreign body reaction, which increased in intensity over time. The patient was eventually treated with a COX-2 inhibitor and the remaining mass was stabilized. In the two DT lesions of the second patient, CTNNB1 mutations S45P and T41A were found. The presence of different mutations in multiple focally recurrent sporadic DT lesions indicates that they do not have a clonal relationship. Our data suggest that a CTNNB1 mutation is a necessary event probably by providing a selective growth advantage. An IgG4 host antigen response is discussed as a potential predisposing factor for one of the patients.
Literature
1.
go back to reference Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F (2013) Tumours of soft tissue and bone: pathology and genetics. In: World Health Organization classification of tumours, 4th edn. IARC Press, Lyon Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F (2013) Tumours of soft tissue and bone: pathology and genetics. In: World Health Organization classification of tumours, 4th edn. IARC Press, Lyon
2.
go back to reference Pikaar A, Nortier JW, Griffioen G, Vasen HF (2002) Desmoid tumors in patients with familial adenomatous polyposis. Ned Tijdschr Geneeskd 146:1355–1359PubMed Pikaar A, Nortier JW, Griffioen G, Vasen HF (2002) Desmoid tumors in patients with familial adenomatous polyposis. Ned Tijdschr Geneeskd 146:1355–1359PubMed
3.
go back to reference Bertario L, Russo A, Sala P, Varesco L, Giarola M, Mondini P et al (2003) Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol 21:1698–1707CrossRefPubMed Bertario L, Russo A, Sala P, Varesco L, Giarola M, Mondini P et al (2003) Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol 21:1698–1707CrossRefPubMed
5.
go back to reference Reitamo JJ, Hayry P, Nykyri E, Saxen E (1982) The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 77:665–673CrossRefPubMed Reitamo JJ, Hayry P, Nykyri E, Saxen E (1982) The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 77:665–673CrossRefPubMed
6.
go back to reference Escobar C, Munker R, Thomas JO, Li BD, Burton GV (2012) Update on desmoid tumors. Ann Oncol 23:562–569CrossRefPubMed Escobar C, Munker R, Thomas JO, Li BD, Burton GV (2012) Update on desmoid tumors. Ann Oncol 23:562–569CrossRefPubMed
7.
go back to reference Le Guellec S, Soubeyran I, Rochaix P, Filleron T, Neuville A, Hostein I et al (2012) CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics. Mod Pathol 25:1551–1558CrossRefPubMed Le Guellec S, Soubeyran I, Rochaix P, Filleron T, Neuville A, Hostein I et al (2012) CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics. Mod Pathol 25:1551–1558CrossRefPubMed
8.
go back to reference Tejpar S, Nollet F, Li C, Wunder JS, Michils G, Dal Cin P et al (1999) Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18:6615–6620CrossRefPubMed Tejpar S, Nollet F, Li C, Wunder JS, Michils G, Dal Cin P et al (1999) Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18:6615–6620CrossRefPubMed
9.
go back to reference Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E et al (2008) Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 173:1518–1527CrossRefPubMedPubMedCentral Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E et al (2008) Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol 173:1518–1527CrossRefPubMedPubMedCentral
10.
go back to reference Salas S, Chibon F, Noguchi T, Terrier P, Ranchere-Vince D, Lagarde P et al (2010) Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors. Genes Chromosomes Cancer 49:560–568PubMed Salas S, Chibon F, Noguchi T, Terrier P, Ranchere-Vince D, Lagarde P et al (2010) Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors. Genes Chromosomes Cancer 49:560–568PubMed
11.
go back to reference Grunhagen DJ, De Wilt JH, Verhoef C, Van Geel AN, Eggermont AM (2005) TNF-based isolated limb perfusion in unresectable extremity desmoid tumours. Eur J Surg Oncol 31:912–916CrossRefPubMed Grunhagen DJ, De Wilt JH, Verhoef C, Van Geel AN, Eggermont AM (2005) TNF-based isolated limb perfusion in unresectable extremity desmoid tumours. Eur J Surg Oncol 31:912–916CrossRefPubMed
12.
go back to reference Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu YS et al (1997) The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys 39:659–665CrossRefPubMed Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu YS et al (1997) The role of adjuvant radiotherapy in the treatment of resectable desmoid tumors. Int J Radiat Oncol Biol Phys 39:659–665CrossRefPubMed
13.
go back to reference Harnet JC, Pedeutour F, Raybaud H, Ambrosetti D, Fabas T, Lombardi T (2013) Immunohistological features in adenomatoid odontogenic tumor: review of the literature and first expression and mutational analysis of beta-catenin in this unusual lesion of the jaws. J Oral Maxillofac Surg 71:706–713CrossRefPubMed Harnet JC, Pedeutour F, Raybaud H, Ambrosetti D, Fabas T, Lombardi T (2013) Immunohistological features in adenomatoid odontogenic tumor: review of the literature and first expression and mutational analysis of beta-catenin in this unusual lesion of the jaws. J Oral Maxillofac Surg 71:706–713CrossRefPubMed
14.
go back to reference Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787–1790CrossRefPubMed Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787–1790CrossRefPubMed
15.
go back to reference Van Broekhoven DL, Verhoef C, Grunhagen DJ, Van Gorp JM, Den Bakker MA, Hinrichs JW et al (2014) Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis. Ann Surg Oncol 22(5):1464–70CrossRefPubMed Van Broekhoven DL, Verhoef C, Grunhagen DJ, Van Gorp JM, Den Bakker MA, Hinrichs JW et al (2014) Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis. Ann Surg Oncol 22(5):1464–70CrossRefPubMed
16.
go back to reference Mullen JT, DeLaney TF, Rosenberg AE, Le L, Iafrate AJ, Kobayashi W et al (2013) Beta-catenin mutation status and outcomes in sporadic desmoid tumors. Oncologist 18:1043–1049CrossRefPubMedPubMedCentral Mullen JT, DeLaney TF, Rosenberg AE, Le L, Iafrate AJ, Kobayashi W et al (2013) Beta-catenin mutation status and outcomes in sporadic desmoid tumors. Oncologist 18:1043–1049CrossRefPubMedPubMedCentral
17.
go back to reference Iwama T, Kuwabara K, Ushiama M, Yoshida T, Sugano K, Ishida H (2009) Identification of somatic APC mutations in recurrent desmoid tumors in a patient with familial adenomatous polyposis to determine actual recurrence of the original tumor or de novo occurrence. Fam Cancer 8:51–54CrossRefPubMed Iwama T, Kuwabara K, Ushiama M, Yoshida T, Sugano K, Ishida H (2009) Identification of somatic APC mutations in recurrent desmoid tumors in a patient with familial adenomatous polyposis to determine actual recurrence of the original tumor or de novo occurrence. Fam Cancer 8:51–54CrossRefPubMed
18.
go back to reference Baschinsky DY, Isa A, Niemann TH, Prior TW, Lucas JG, Frankel WL (2000) Diffuse leiomyomatosis of the uterus: a case report with clonality analysis. Hum Pathol 31:1429–1432CrossRefPubMed Baschinsky DY, Isa A, Niemann TH, Prior TW, Lucas JG, Frankel WL (2000) Diffuse leiomyomatosis of the uterus: a case report with clonality analysis. Hum Pathol 31:1429–1432CrossRefPubMed
19.
go back to reference Agaimy A, Dirnhofer S, Wunsch PH, Terracciano LM, Tornillo L, Bihl MP (2008) Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect. Am J Surg Pathol 32:1553–1559CrossRefPubMed Agaimy A, Dirnhofer S, Wunsch PH, Terracciano LM, Tornillo L, Bihl MP (2008) Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect. Am J Surg Pathol 32:1553–1559CrossRefPubMed
20.
go back to reference Chmara M, Wernstedt A, Wasag B, Peeters H, Renard M, Beert E et al (2013) Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency. Genes Chromosomes Cancer 52:656–664PubMed Chmara M, Wernstedt A, Wasag B, Peeters H, Renard M, Beert E et al (2013) Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency. Genes Chromosomes Cancer 52:656–664PubMed
21.
go back to reference Stone JH (2012) IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol 29:177–190CrossRefPubMed Stone JH (2012) IgG4-related disease: nomenclature, clinical features, and treatment. Semin Diagn Pathol 29:177–190CrossRefPubMed
22.
go back to reference Ebbo M, Daniel L, Pavic M, Seve P, Hamidou M, Andres E et al (2012) IgG4-related systemic disease: features and treatment response in a French cohort. results of a multicenter registry Medicine (Baltimore) 91:49–56CrossRef Ebbo M, Daniel L, Pavic M, Seve P, Hamidou M, Andres E et al (2012) IgG4-related systemic disease: features and treatment response in a French cohort. results of a multicenter registry Medicine (Baltimore) 91:49–56CrossRef
Metadata
Title
Spatio-temporal genetic heterogeneity of CTNNB1 mutations in sporadic desmoid type fibromatosis lesions
Authors
Jérôme Doyen
Valérie Duranton-Tanneur
Isabelle Hostein
Marie Karanian-Philippe
Christine Chevreau
Florence Breibach
Michael Coutts
Bérengère Dadone
Marie-Christine Saint-Paul
Jean Gugenheim
Florence Duffaud
Florence Pedeutour
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
Virchows Archiv / Issue 3/2016
Print ISSN: 0945-6317
Electronic ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-015-1883-8

Other articles of this Issue 3/2016

Virchows Archiv 3/2016 Go to the issue

Editorial

In this issue